NCT03427892View on ClinicalTrials.gov

Brexpiprazole for Bipolar Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

March 15, 2018

Study Completion Date

March 15, 2018

Conditions
Bipolar Depression
Interventions
DRUG

Brexpiprazole

Brexpiprazole is an atypical antipsychotic drug that is used to treat mental/mood disorders.

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Otsuka America Pharmaceutical

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT03427892 - Brexpiprazole for Bipolar Depression | Biotech Hunter | Biotech Hunter